July 8, 2013

A chronic obstructive pulmonary disease and asthma drug made by Sunovion infringes Mylan's patents on a similar drug, a federal judge has ruled, Mylan said.

June 10, 2013

Anglo-Swedish drug maker AstraZeneca will pay up to $1.15 billion for a U.S. developer of drugs for respiratory diseases, AstraZeneca said Monday.

May 21, 2013

A federal appellate court has ruled in favor of Mylan in a case involving a drug for chronic obstructive pulmonary disease, the drug maker said.

November 14, 2010

Most patients with mild persistent asthma overuse a drug combination despite an apparent lack of...

June 23, 2010

The Food and Drug Administration has approved a new drug by Merck for treating asthma...

June 6, 2010

The class of drugs known as long-acting beta agonists can provide many benefits to patients...

May 10, 2010

Nearly one-third of patients with asthma are taking their medications in a way that puts...

February 24, 2010

Mylan had profits of $93.5 million in 2009, the generic drug maker announced Thursday in...

February 18, 2010

British drug maker GlaxoSmithKline issued a response to new labeling requirements proposed by the Food...

February 17, 2010

Drugs belonging to the class called long-acting beta agonists should never be used alone for...